Inventiva S.A. Financials

IVA

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2021 Currency USD FYE December

This page shows Inventiva S.A. (IVA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

N/A

EBITDA

N/A

Net Income

-$49.6M

Inventiva S.A. reported -$49.6M in net income in fiscal year 2021.

EPS (Diluted)

N/A

Cash & Balance Sheet

Free Cash Flow

N/A

Cash & Debt

N/A

Dividends Per Share

N/A

Shares Outstanding

41M

Inventiva S.A. had 41M shares outstanding in fiscal year 2021.

Margins & Returns

Gross Margin

N/A

Operating Margin

N/A

Net Margin

N/A

Return on Equity

-55.9%

Inventiva S.A.'s ROE was -55.9% in fiscal year 2021, measuring profit generated per dollar of shareholder equity.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

N/A

IVA Income Statement

Metric	Q4'21
Revenue	N/A
Cost of Revenue	N/A
Gross Profit	N/A
R&D Expenses	N/A
SG&A Expenses	N/A
Operating Income	N/A
Interest Expense	N/A
Income Tax	N/A
Net Income	N/A
EPS (Diluted)	N/A

IVA Balance Sheet

Metric	Q4'21
Total Assets	$122.0M
Current Assets	N/A
Cash & Equivalents	N/A
Inventory	N/A
Accounts Receivable	N/A
Goodwill	N/A
Total Liabilities	$33.1M
Current Liabilities	N/A
Long-Term Debt	N/A
Total Equity	$88.9M
Retained Earnings	N/A

IVA Financial Ratios

Metric	Q4'21
Gross Margin	N/A
Operating Margin	N/A
Net Margin	N/A
Return on Equity	N/A
Return on Assets	N/A
Current Ratio	N/A
Debt-to-Equity	0.37
FCF Margin	N/A

Similar Companies

Immunome Inc IMNM

$2.5B

Geron Corp GERN

$1.1B

Praxis Precision Medicines, Inc. PRAX

$8.6B

Anavex Life Scie AVXL

$277.1M

BridgeBio Oncology Therapeutics, Inc BBOT

$713.1M

Frequently Asked Questions

Is Inventiva S.A. profitable?

No, Inventiva S.A. (IVA) reported a net income of -$49.6M in fiscal year 2021.

What is Inventiva S.A.'s return on equity (ROE)?

Inventiva S.A. (IVA) has a return on equity of -55.9% for fiscal year 2021, measuring how efficiently the company generates profit from shareholder equity.

What are Inventiva S.A.'s total assets?

Inventiva S.A. (IVA) had $122.0M in total assets as of fiscal year 2021, including both current and long-term assets.

How many shares does Inventiva S.A. have outstanding?

Inventiva S.A. (IVA) had 41M shares outstanding as of fiscal year 2021.

What is Inventiva S.A.'s debt-to-equity ratio?

Inventiva S.A. (IVA) had a debt-to-equity ratio of 0.37 as of fiscal year 2021, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Inventiva S.A.'s return on assets (ROA)?

Inventiva S.A. (IVA) had a return on assets of -40.7% for fiscal year 2021, measuring how efficiently the company uses its assets to generate profit.